Annual long term liabilities:
$14.62B+$8.94B(+157.28%)Summary
- As of today (May 29, 2025), NVO annual total long term liabilities is $14.62 billion, with the most recent change of +$8.94 billion (+157.28%) on December 31, 2024.
- During the last 3 years, NVO annual long term liabilities has risen by +$10.93 billion (+296.05%).
- NVO annual long term liabilities is now at all-time high.
Performance
NVO Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$16.61B+$1.99B(+13.62%)Summary
- As of today (May 29, 2025), NVO quarterly total long term liabilities is $16.61 billion, with the most recent change of +$1.99 billion (+13.62%) on March 31, 2025.
- Over the past year, NVO quarterly long term liabilities has increased by +$11.63 billion (+233.75%).
- NVO quarterly long term liabilities is now at all-time high.
Performance
NVO quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
NVO Long term liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +157.3% | +233.8% |
3 y3 years | +296.1% | +216.4% |
5 y5 years | +979.1% | +1197.2% |
NVO Long term liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +296.1% | at high | +250.1% |
5 y | 5-year | at high | +979.1% | at high | +1197.2% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
NVO Long term liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $16.61B(+13.6%) |
Dec 2024 | $14.62B(+157.3%) | $14.62B(+42.4%) |
Sep 2024 | - | $10.27B(+3.7%) |
Jun 2024 | - | $9.90B(+98.9%) |
Mar 2024 | - | $4.98B(-12.4%) |
Dec 2023 | $5.68B(+7.2%) | $5.68B(+16.1%) |
Sep 2023 | - | $4.89B(-0.4%) |
Jun 2023 | - | $4.91B(-12.1%) |
Mar 2023 | - | $5.59B(+5.5%) |
Dec 2022 | $5.30B(+43.6%) | $5.30B(+11.7%) |
Sep 2022 | - | $4.74B(-2.9%) |
Jun 2022 | - | $4.89B(-6.9%) |
Mar 2022 | - | $5.25B(+42.2%) |
Dec 2021 | $3.69B(+97.2%) | $3.69B(+20.4%) |
Sep 2021 | - | $3.06B(-3.0%) |
Jun 2021 | - | $3.16B(+90.7%) |
Mar 2021 | - | $1.66B(-11.5%) |
Dec 2020 | $1.87B(+38.2%) | $1.87B(+25.9%) |
Sep 2020 | - | $1.49B(+12.2%) |
Jun 2020 | - | $1.32B(+3.5%) |
Mar 2020 | - | $1.28B(-5.5%) |
Dec 2019 | $1.35B(+85.5%) | $1.35B(+4.2%) |
Sep 2019 | - | $1.30B(+3.7%) |
Jun 2019 | - | $1.25B(+3.6%) |
Mar 2019 | - | $1.21B(+65.8%) |
Dec 2018 | $730.10M(-17.4%) | $730.10M(-5.4%) |
Sep 2018 | - | $771.42M(-0.3%) |
Jun 2018 | - | $773.74M(-9.2%) |
Mar 2018 | - | $851.73M(-3.6%) |
Dec 2017 | $883.75M(+28.6%) | $883.75M(-4.0%) |
Sep 2017 | - | $920.87M(+7.6%) |
Jun 2017 | - | $856.06M(+19.0%) |
Mar 2017 | - | $719.54M(+4.7%) |
Dec 2016 | $687.44M(+18.6%) | $687.44M(+3.3%) |
Sep 2016 | - | $665.36M(+7.1%) |
Jun 2016 | - | $621.41M(+1.9%) |
Mar 2016 | - | $609.68M(+5.2%) |
Dec 2015 | $579.62M(+15.3%) | $579.62M(+7.8%) |
Sep 2015 | - | $537.44M(-0.9%) |
Jun 2015 | - | $542.54M(+11.4%) |
Mar 2015 | - | $487.10M(-3.1%) |
Dec 2014 | $502.71M(-23.3%) | $502.71M(-10.2%) |
Sep 2014 | - | $559.96M(-6.5%) |
Jun 2014 | - | $598.61M(-0.3%) |
Mar 2014 | - | $600.45M(-8.4%) |
Dec 2013 | $655.77M(+8.9%) | $655.77M(+8.2%) |
Sep 2013 | - | $606.12M(-1.2%) |
Jun 2013 | - | $613.65M(+18.2%) |
Mar 2013 | - | $519.05M(-13.8%) |
Dec 2012 | $602.44M | $602.44M(-26.5%) |
Sep 2012 | - | $819.69M(-15.4%) |
Jun 2012 | - | $969.18M(-21.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2012 | - | $1.23B(+8.8%) |
Dec 2011 | $1.13B(+6.0%) | $1.13B(-0.8%) |
Sep 2011 | - | $1.14B(-1.7%) |
Jun 2011 | - | $1.16B(+2.2%) |
Mar 2011 | - | $1.13B(+6.4%) |
Dec 2010 | $1.06B(-1.2%) | $1.06B(-2.5%) |
Sep 2010 | - | $1.09B(+29.7%) |
Jun 2010 | - | $841.27M(-18.9%) |
Mar 2010 | - | $1.04B(-3.6%) |
Dec 2009 | $1.08B(+22.5%) | $1.08B(+14.4%) |
Sep 2009 | - | $940.47M(+6.5%) |
Jun 2009 | - | $883.03M(+5.3%) |
Mar 2009 | - | $838.90M(-4.5%) |
Dec 2008 | $878.35M(-8.6%) | $878.35M(+3.4%) |
Sep 2008 | - | $849.20M(-8.8%) |
Jun 2008 | - | $931.52M(-5.7%) |
Mar 2008 | - | $988.29M(+2.8%) |
Dec 2007 | $961.09M(+23.3%) | $961.09M(+11.8%) |
Sep 2007 | - | $859.52M(+10.3%) |
Jun 2007 | - | $779.00M(-1.5%) |
Mar 2007 | - | $791.00M(+1.5%) |
Dec 2006 | $779.55M(+31.5%) | $779.55M(+15.5%) |
Sep 2006 | - | $675.00M(-1.8%) |
Jun 2006 | - | $687.42M(+12.8%) |
Mar 2006 | - | $609.33M(+2.8%) |
Dec 2005 | $593.00M(-11.4%) | $593.00M(-13.8%) |
Sep 2005 | - | $687.62M(+34.2%) |
Jun 2005 | - | $512.26M(-11.6%) |
Mar 2005 | - | $579.32M(-13.4%) |
Dec 2004 | $669.34M(+55.3%) | $669.34M(+51.1%) |
Sep 2004 | - | $443.10M(+2.4%) |
Jun 2004 | - | $432.52M(-6.3%) |
Mar 2004 | - | $461.69M(+7.1%) |
Dec 2003 | $431.01M(+17.5%) | $431.01M(+17.5%) |
Dec 2002 | $366.68M(+12.2%) | $366.68M(+12.2%) |
Dec 2001 | $326.71M(+7.8%) | $326.71M(+7.8%) |
Dec 2000 | $303.03M(-0.8%) | $303.03M(-0.8%) |
Dec 1999 | $305.33M(-49.0%) | $305.33M(-49.0%) |
Dec 1998 | $598.57M(+85.7%) | $598.57M(+85.7%) |
Dec 1997 | $322.29M(+41.8%) | $322.29M(+41.8%) |
Dec 1996 | $227.23M(-29.4%) | $227.23M(-29.4%) |
Dec 1995 | $322.08M(-42.7%) | $322.08M(-42.7%) |
Dec 1994 | $561.81M(+5.8%) | $561.81M(+5.8%) |
Dec 1993 | $530.95M(+18.8%) | $530.95M(+18.8%) |
Dec 1992 | $447.01M(+38.1%) | $447.01M(+38.1%) |
Dec 1991 | $323.71M(+43.6%) | $323.71M(+43.6%) |
Dec 1990 | $225.37M(-15.0%) | $225.37M(-15.0%) |
Dec 1989 | $265.19M(+87.6%) | $265.19M(+87.6%) |
Dec 1988 | $141.34M(-12.3%) | $141.34M(-12.3%) |
Dec 1987 | $161.14M(-37.0%) | $161.14M(-37.0%) |
Dec 1986 | $255.73M(+171.9%) | $255.73M(+171.9%) |
Dec 1985 | $94.04M(+58.7%) | $94.04M(+58.7%) |
Dec 1984 | $59.27M | $59.27M |
FAQ
- What is Novo Nordisk A/S annual total long term liabilities?
- What is the all time high annual long term liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual long term liabilities year-on-year change?
- What is Novo Nordisk A/S quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly long term liabilities year-on-year change?
What is Novo Nordisk A/S annual total long term liabilities?
The current annual long term liabilities of NVO is $14.62B
What is the all time high annual long term liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total long term liabilities is $14.62B
What is Novo Nordisk A/S annual long term liabilities year-on-year change?
Over the past year, NVO annual total long term liabilities has changed by +$8.94B (+157.28%)
What is Novo Nordisk A/S quarterly total long term liabilities?
The current quarterly long term liabilities of NVO is $16.61B
What is the all time high quarterly long term liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total long term liabilities is $16.61B
What is Novo Nordisk A/S quarterly long term liabilities year-on-year change?
Over the past year, NVO quarterly total long term liabilities has changed by +$11.63B (+233.75%)